**Core Concept**
Sulfonamides are a class of antimicrobials that act by inhibiting the synthesis of folic acid in bacteria. This is achieved through a competitive inhibition of the enzyme dihydropteroate synthase (DHPS), which is essential for the conversion of para-aminobenzoic acid (PABA) to dihydrofolate.

**Why the Correct Answer is Right**
Sulfonamides structurally resemble PABA and competitively inhibit the action of DHPS, thereby preventing the formation of dihydrofolate. This inhibition disrupts the bacterial folate synthesis pathway, ultimately leading to a deficiency of tetrahydrofolic acid (THFA) and impaired DNA synthesis and cell division. The inhibition of DHPS is a critical step in the sulfonamide mechanism of action, as it prevents the bacteria from producing the necessary folate derivatives required for nucleic acid synthesis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because sulfonamides do not inhibit bacterial protein synthesis. Sulfonamides target the folate synthesis pathway, not the protein synthesis pathway.

**Option B:** This option is incorrect because sulfonamides do not inhibit bacterial cell wall synthesis. Sulfonamides act by disrupting the bacterial folate synthesis pathway, which is essential for DNA synthesis and cell division.

**Option C:** This option is incorrect because sulfonamides do not inhibit bacterial DNA replication. While sulfonamides do disrupt DNA synthesis by inhibiting folate synthesis, they do not directly inhibit DNA replication.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that sulfonamides are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, as they can induce hemolysis in these individuals.

**Correct Answer: C. Competitive inhibition of dihydropteroate synthase (DHPS).**